Prelude Therapeutics to Showcase at Citizens JMP Life Sciences Conference

Prelude Therapeutics

WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) will take the stage at the upcoming Citizens JMP Life Sciences Conference in New York City on May 13 and 14.

CEO Kris Vaddi, Ph.D., alongside President and Chief Medical Officer Jane Huang, M.D., will engage in a fireside chat on Tuesday, May 14, at 1:00 p.m. ET.

The discussion aims to provide insights into the company’s latest developments and future plans.

Attendees can join the live webcast through the company’s website under Events and Presentations, where the session will also be archived for 90 days post-event for broader access.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.

READ:  Ocugen's CSO to Highlight Gene Therapy Advances at Upcoming Conference